Evolent Health, Inc. EVH Debt Issuance Cost Amortization
Debt Issuance Cost Amortization at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s debt issuance cost amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s debt issuance cost amortization?
- Evolent Health, Inc. (EVH) reported debt issuance cost amortization of $2.95M in Q1 2026.
- How has Evolent Health, Inc.'s debt issuance cost amortization changed year-over-year?
- Evolent Health, Inc.'s debt issuance cost amortization increased by 155.5% year-over-year, from $1.15M to $2.95M.
- What is the long-term trend for Evolent Health, Inc.'s debt issuance cost amortization?
- Over 4 years (2021 to 2025), Evolent Health, Inc.'s debt issuance cost amortization has grown at a -18.9% compound annual growth rate (CAGR), from $18.05M to $7.8M.
- What does debt issuance cost amortization mean?
- Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).